Skip to main content
SSRI Logo
  • Home
  • About
    SSRI Overview Institutes and Centers Faculty Affiliate Program
  • People
    All Directors Unit Directors Staff Deans' Council Cofunded Faculty Faculty Affiliates
  • Funding
  • Research Services
  • Research Centers
  • Workgroups
  • Events
    Upcoming Events SSRI Open House IFSE Workshop Workshop Resources Event Galleries Past Events
  • News
  1. Home

For privately sponsored studies that are conducted pursuant to a private sponsor’s protocol (industry sponsor), the sponsor of the study is required to pay for the reasonable cost of treating injuries or complications directly resulting from participation in the study, including injuries or complications resulting from the study material or research procedures performed pursuant to the study protocol, to the extent that injuries/complications were not a result of negligence, willful misconduct or failure to reasonably act on the part of the study personnel.

  • Read more about Subject Injury and Complications

The Office for Research Protections Quality Assurance Program is available to assist with IND preparation, submission, and maintenance. Contact them at orp-qm@psu.edu.

For guidance and templates for your IND application, see the Quality Assurance Program’s resources.

  • Read more about Assistance for IND Preparation

Sponsor-Investigator responsibilities under an IND or IDE are covered in 21 CFR 312 (for drugs) and 21 CFR 812 (for devices).

  • Read more about Sponsor-Investigator Responsibilities

For more information on Humanitarian Use Devices, see the information provided by the College of Medicine.

  • Read more about Humanitarian Use Device

Premarket approval (PMA) (21 CFR 814.39) is the FDA process of scientific and regulatory review to evaluate the safety and effectiveness of Class III medical devices. Due to the level of risk associated with Class III devices, FDA requires sufficient valid scientific evidence to assure that the device is safe and effective for its intended use(s).

  • Read more about PMA vs 510(k)

For more information on Emergency Use of Unapproved Device, Compassionate Use, and Treatment Use, please see the information provided by the College of Medicine.

  • Read more about Emergency Use of Unapproved Device, Compassionate Use of Investigational Devices, and Treatment Use

Some studies may be exempt from the IDE regulations. The exemption criteria is explained in 21 CFR 812.2(c), and briefly summarized here:

  • Read more about IDE Exemptions

Studies of non-significant risk devices are subject to abbreviated IDE requirements. An IDE submission to the FDA is not required under the abbreviated requirements, but the requirements for labeling, IRB approval, informed consent, monitoring, records, reports and promotional practices contained in FDA regulations still apply (21 CFR 812.2(b)).

Requirements under abbreviated IDE:

  • Read more about Abbreviated IDE

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 296
  • Page 297
  • Page 298
  • Page 299
  • Current page 300
  • Page 301
  • Page 302
  • Page 303
  • Page 304
  • …
  • Next page Next ›
  • Last page Last »

SSRI Logo

Contact SSRI

 Phone: (814) 865-1528
 Email: ssri-info@psu.edu
 Address: 301 Welch Building, University Park, PA 16802


Follow SSRI on

     


About this Website

Sitemap
Questions about this website
IT Help
Admin Login

Penn State

Privacy | Non-discrimination | Equal Opportunity | Accessibility | Copyright

© 2025 Social Science Research Institute. All rights reserved.